Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia

Liang, XL; Xia, RX

Xia, RX (通讯作者),Anhui Med Univ, Dept Hematol, Affiliated Hosp 1, 218 Jixi Rd, Hefei 230022, Anhui, Peoples R China.

ONCOLOGY REPORTS, 2022; 47 (1):

Abstract

KIF2A has been shown to be involved in the regulation of AML pathology, however, the mechanistic role of KIF2A in AML has not been fully identified. T......

Full Text Link